Shares of NPS Pharmaceuticals, Inc. (NPSP) are up nearly 9% to $45.45 in early trade Monday after the New Jersey-based drugmaker said it agreed to be bought by Ireland’s Shire plc (SHPG) for $5.2 billion in cash. Shire will pay $46 per share for NPSP. That’s a 9.8% premium to ticker’s $41.91 closing pps on […]
View the full post at: Morning Buzz: NPS Pharmaceuticals (NPSP), Tekmira Pharmaceuticals (TKMR), Agenus Inc. (AGEN), Arrowhead Research (ARWR)